Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrika S H Simonsson

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Frontiers in Pharmacology|June 16, 2020
Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing-Using Rifampicin as an ExampleLina Keutzer, Ulrika S H Simonsson
British Journal of Clinical Pharmacology|January 29, 2011
Modelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administrationMarcus A Björnsson, Ulrika S H Simonsson
CPT: Pharmacometrics & Systems Pharmacology|April 25, 2022
Finding the right hazard function for time-to-event modeling: A tutorial and Shiny applicationRob C Van Wijk, Ulrika S H Simonsson
Rapid Communications in Mass Spectrometry : RCM|January 6, 2006
Enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma and urine by liquid chromatography/tandem mass spectrometryBritt Jansson, Doaa Elsherbiny, Ulrika S H Simonsson
Journal of Pharmacokinetics and Pharmacodynamics|February 20, 2013
D optimal designs for three Poisson dose-response modelsAlan Maloney, Ulrika S H Simonsson, Marloes Schaddelee
Journal of Pharmacokinetics and Pharmacodynamics|July 12, 2013
Model based design and analysis of phase II HIV-1 trialsDinko Rekić, Daniel Röshammar, Ulrika S H Simonsson
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 12, 2003
Simultaneous enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma by liquid chromatographyBritt Jansson, Ulrika S H Simonsson, Michael Ashton
Journal of Clinical Pharmacology|October 2, 2007
Optimal adaptive design in clinical drug development: a simulation exampleAlan Maloney, Mats O Karlsson, Ulrika S H Simonsson
Anesthesiology|February 23, 2008
Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphineEmma Boström, Margareta Hammarlund-Udenaes, Ulrika S H Simonsson
Journal of Pharmacokinetics and Pharmacodynamics|August 29, 2015
Evaluation of optimized bronchoalveolar lavage sampling designs for characterization of pulmonary drug distributionOskar Clewe, Mats O Karlsson, Ulrika S H Simonsson
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Frontiers in Pharmacology|June 16, 2020
Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing-Using Rifampicin as an ExampleLina Keutzer, Ulrika S H Simonsson
British Journal of Clinical Pharmacology|January 29, 2011
Modelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administrationMarcus A Björnsson, Ulrika S H Simonsson
CPT: Pharmacometrics & Systems Pharmacology|April 25, 2022
Finding the right hazard function for time-to-event modeling: A tutorial and Shiny applicationRob C Van Wijk, Ulrika S H Simonsson
Rapid Communications in Mass Spectrometry : RCM|January 6, 2006
Enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma and urine by liquid chromatography/tandem mass spectrometryBritt Jansson, Doaa Elsherbiny, Ulrika S H Simonsson
Journal of Pharmacokinetics and Pharmacodynamics|February 20, 2013
D optimal designs for three Poisson dose-response modelsAlan Maloney, Ulrika S H Simonsson, Marloes Schaddelee
Journal of Pharmacokinetics and Pharmacodynamics|July 12, 2013
Model based design and analysis of phase II HIV-1 trialsDinko Rekić, Daniel Röshammar, Ulrika S H Simonsson
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 12, 2003
Simultaneous enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma by liquid chromatographyBritt Jansson, Ulrika S H Simonsson, Michael Ashton
Journal of Clinical Pharmacology|October 2, 2007
Optimal adaptive design in clinical drug development: a simulation exampleAlan Maloney, Mats O Karlsson, Ulrika S H Simonsson
Anesthesiology|February 23, 2008
Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphineEmma Boström, Margareta Hammarlund-Udenaes, Ulrika S H Simonsson
Journal of Pharmacokinetics and Pharmacodynamics|August 29, 2015
Evaluation of optimized bronchoalveolar lavage sampling designs for characterization of pulmonary drug distributionOskar Clewe, Mats O Karlsson, Ulrika S H Simonsson
Pageof 11